egtazic acid has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, T; Inokuchi, K; Kato, N; Sakagami, Y; Sugiura, S; Yamamoto, K | 1 |
Anwyl, R; Harney, SC; Rowan, M | 1 |
Hillard, CJ; Liu, QS; Pan, B | 1 |
Araque, A; Navarrete, M | 1 |
Nuriya, M; Shinotsuka, T; Yasui, M | 1 |
5 other study(ies) available for egtazic acid and 6-methyl-2-(phenylethynyl)pyridine
Article | Year |
---|---|
Essential roles of Homer-1a in homeostatic regulation of pyramidal cell excitability: a possible link to clinical benefits of electroconvulsive shock.
Topics: Animals; Animals, Newborn; Carrier Proteins; Charybdotoxin; Chelating Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Egtazic Acid; Electroshock; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Heparin; Homer Scaffolding Proteins; Membrane Potentials; Neocortex; Patch-Clamp Techniques; Potassium Channel Blockers; Pyramidal Cells; Pyridines; Rats; Rats, Wistar; Recombinant Proteins; Seizures; Time Factors | 2005 |
Long-term depression of NMDA receptor-mediated synaptic transmission is dependent on activation of metabotropic glutamate receptors and is altered to long-term potentiation by low intracellular calcium buffering.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Animals; Buffers; Calcium; Dentate Gyrus; Egtazic Acid; Electric Stimulation; Excitatory Amino Acid Antagonists; Long-Term Synaptic Depression; Male; Patch-Clamp Techniques; Perforant Pathway; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Xanthenes | 2006 |
D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling.
Topics: Analysis of Variance; Animals; Animals, Newborn; Benzoxazines; Chromones; Cocaine; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Drug Combinations; Egtazic Acid; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; In Vitro Techniques; Long-Term Synaptic Depression; Male; Mesencephalon; Mice; Mice, Knockout; Morpholines; Naphthalenes; Neurons; Patch-Clamp Techniques; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2 | 2008 |
Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes.
Topics: Animals; Animals, Newborn; Astrocytes; Benzoates; Biophysics; Calcium; Cannabinoid Receptor Modulators; Chelating Agents; Drug Interactions; Egtazic Acid; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glycine; Hippocampus; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Knockout; Patch-Clamp Techniques; Photolysis; Piperidines; Pyramidal Cells; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB1; Resorcinols; Synaptic Transmission; Thapsigargin | 2010 |
Astrocytic gap junctional networks suppress cellular damage in an in vitro model of ischemia.
Topics: Animals; Astrocytes; Calcium Signaling; Carbenoxolone; Cell Hypoxia; Cerebral Cortex; Chelating Agents; Egtazic Acid; Female; Gap Junctions; Glucose; Ischemia; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; Models, Biological; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Purinergic P2; Suramin; Time-Lapse Imaging | 2014 |